Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL).
Andres Forero-Torres
Research Funding - Seattle Genetics
Other Remuneration - Seattle Genetics
Craig Moskowitz
Consultant or Advisory Role - Seattle Genetics (U)
Research Funding - Seattle Genetics
Ranjana H. Advani
Consultant or Advisory Role - Seattle Genetics (U)
Research Funding - Seattle Genetics
Bijal D. Shah
Research Funding - Seattle Genetics
Ana Kostic
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Tina M. Albertson
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Larissa Sandalic
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Baiteng Zhao
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Michelle A. Fanale
Consultant or Advisory Role - Seattle Genetics (U)
Honoraria - Seattle Genetics
Research Funding - Seattle Genetics
Other Remuneration - Seattle Genetics